Levi David, Horn Scott, Corcoran Sarah
*APM Spine and Sports Physicians, Norfolk, Virginia, USA
*APM Spine and Sports Physicians, Norfolk, Virginia, USA.
Pain Med. 2016 Aug;17(8):1416-22. doi: 10.1093/pm/pnv067. Epub 2015 Dec 24.
Lumbar transforaminal epidural steroid injections (TFESIs) are often used in the treatment of radicular pain. In light of safety concerns, many practitioners have proposed adopting the retrodiscal (infraneural) approach with the needle tip positioned into Kambin's triangle. With this technique, the needle may inadvertently be directed too far ventrally and enter the intervertebral disc. In addition, the risk of subarachnoid or subdural extra-arachnoid injection may be higher with this technique as well.
To determine the incidence of inadvertent intradiscal, intrathecal, and vascular injections during the performance of retrodiscal TFESI.
Retrospective review
Retrospective review of all retrodiscal approach TFESIs performed from July 2012 to August 2014 by two of the authors (DL and SH).
A total of 257 retrodiscal transforaminal injections were performed. There were no neurologic complications. There were no cases of discitis. Inadvertent intradiscal injections occurred in 12/257 injections, 4.7% (95% CI 2.1-7.3%). Intrathecal injections occurred in 8/257 injections, 3.1% (95% CI 0.99- 5.23%). Three were subarachnoid (SA), four were subdural extra-arachnoid (SDXA), and one was both SA and SDXA. Vascular injections occurred in 17/257, 6.6% (95% CI 3.6-9.6%).
This retrospective review demonstrates that a relatively high rate of inadvertent intradiscal injections occurs in the performance of the retrodiscal approach for TFESI. This has significant implications in terms of the potential risk of disc injury induced by the needle puncture. The high incidence of intrathecal injections may also be of great concern depending upon the injectate delivered.
腰椎经椎间孔硬膜外类固醇注射(TFESI)常用于治疗神经根性疼痛。鉴于安全问题,许多从业者建议采用针尖端位于坎宾三角的椎间盘后(神经下)入路。采用这种技术时,针可能会无意中过于向腹侧进针并进入椎间盘。此外,采用这种技术时蛛网膜下腔或硬膜下蛛网膜外注射的风险可能也更高。
确定在进行椎间盘后TFESI过程中意外椎间盘内、鞘内及血管内注射的发生率。
回顾性研究
对2012年7月至2014年8月由两位作者(DL和SH)进行的所有椎间盘后入路TFESI进行回顾性研究。
共进行了257次椎间盘后经椎间孔注射。未发生神经并发症。无椎间盘炎病例。12/257次注射发生意外椎间盘内注射,发生率为4.7%(95%置信区间2.1 - 7.3%)。8/257次注射发生鞘内注射,发生率为3.1%(95%置信区间0.99 - 5.23%)。其中3次为蛛网膜下腔(SA)注射,4次为硬膜下蛛网膜外(SDXA)注射,1次同时为SA和SDXA注射。17/257次注射发生血管内注射,发生率为6.6%(95%置信区间3.6 - 9.6%)。
这项回顾性研究表明,在进行椎间盘后入路TFESI时,意外椎间盘内注射的发生率相对较高。这对于针刺导致椎间盘损伤的潜在风险具有重要意义。根据所注入的物质,鞘内注射的高发生率也可能令人高度关注。